- Investing Ideas
- /
- Utilities Healthcare Sector
Utilities Healthcare Sector
Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
Neurocrine Biosciences
Market Cap: US$11.6b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$115.71
7D
5.5%
1Y
-15.4%
Incyte
Market Cap: US$11.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$58.98
7D
-5.7%
1Y
11.2%
Solventum
Market Cap: US$11.5b
A healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
SOLV
US$70.23
7D
3.9%
1Y
10.2%
Hims & Hers Health
Market Cap: US$11.5b
Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
HIMS
US$51.96
7D
27.3%
1Y
322.8%
BioMarin Pharmaceutical
Market Cap: US$11.5b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$58.86
7D
-5.1%
1Y
-27.4%
Tempus AI
Market Cap: US$11.3b
Operates as a healthcare technology company.
TEM
US$61.37
7D
7.6%
1Y
n/a
Cochlear
Market Cap: AU$17.5b
Provides implantable hearing solutions for children and adults worldwide.
COH
AU$267.55
7D
-2.9%
1Y
-16.5%
Penumbra
Market Cap: US$11.2b
Designs, develops, manufactures, and markets medical devices in the United States and internationally.
PEN
US$297.32
7D
0.4%
1Y
40.1%
Doximity
Market Cap: US$11.1b
Operates a cloud-based digital platform for medical professionals in the United States.
DOCS
US$59.19
7D
-0.2%
1Y
153.3%
DaVita
Market Cap: US$11.0b
Provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
DVA
US$143.76
7D
1.9%
1Y
4.5%
ICON
Market Cap: US$11.0b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$133.96
7D
-6.3%
1Y
-57.5%
Revvity
Market Cap: US$11.0b
Provides health sciences solutions, technologies, and services worldwide.
RVTY
US$91.25
7D
-2.9%
1Y
-12.9%
Viatris
Market Cap: US$10.7b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$8.77
7D
1.4%
1Y
-21.4%
Exelixis
Market Cap: US$10.1b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$36.17
7D
-8.7%
1Y
69.3%
Exact Sciences
Market Cap: US$10.0b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$51.63
7D
0.2%
1Y
-3.5%
Globus Medical
Market Cap: US$9.8b
A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
GMED
US$55.82
7D
-22.4%
1Y
-13.8%
Moderna
Market Cap: US$9.4b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$24.25
7D
-12.2%
1Y
-79.3%
Ascendis Pharma
Market Cap: US$9.1b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$151.25
7D
-12.1%
1Y
13.3%
Qiagen
Market Cap: US$9.1b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$41.86
7D
-2.9%
1Y
-6.7%
Medpace Holdings
Market Cap: US$8.6b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$296.03
7D
-3.0%
1Y
-24.1%
Henry Schein
Market Cap: US$8.4b
Provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide.
HSIC
US$68.64
7D
5.1%
1Y
-6.4%
Avantor
Market Cap: US$8.4b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$12.02
7D
-6.6%
1Y
-51.5%
Halozyme Therapeutics
Market Cap: US$8.3b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO
US$65.87
7D
7.6%
1Y
52.7%
Masimo
Market Cap: US$8.3b
Develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide.
MASI
US$156.57
7D
-5.9%
1Y
28.6%
Chemed
Market Cap: US$8.3b
Provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States.
CHE
US$570.22
7D
-0.9%
1Y
-0.9%
Sonic Healthcare
Market Cap: AU$12.9b
Offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally.
SHL
AU$26.80
7D
2.8%
1Y
0.1%
HealthEquity
Market Cap: US$7.9b
Provides technology-enabled services platforms to consumers and employers in the United States.
HQY
US$90.40
7D
-0.2%
1Y
16.9%
Roivant Sciences
Market Cap: US$7.9b
A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.
ROIV
US$10.64
7D
-7.3%
1Y
-4.4%
Bio-Techne
Market Cap: US$7.9b
Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
TECH
US$49.94
7D
-1.1%
1Y
-38.3%
Revolution Medicines
Market Cap: US$7.8b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$40.42
7D
-0.7%
1Y
8.5%
Ensign Group
Market Cap: US$7.8b
Provides skilled nursing, senior living, and rehabilitative services.
ENSG
US$136.68
7D
3.3%
1Y
15.5%
Corcept Therapeutics
Market Cap: US$7.6b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$70.23
7D
-3.5%
1Y
159.7%
Repligen
Market Cap: US$7.2b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$123.24
7D
-12.9%
1Y
-26.1%
Waystar Holding
Market Cap: US$7.0b
Develops a cloud-based software solution for healthcare payments.
WAY
US$40.01
7D
-1.6%
1Y
n/a
ConvaTec Group
Market Cap: UK£5.3b
Engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally.
CTEC
UK£2.57
7D
-1.8%
1Y
-1.8%
Charles River Laboratories International
Market Cap: US$6.9b
Charles River Laboratories International, Inc.
CRL
US$138.79
7D
17.2%
1Y
-39.2%